These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21190426)

  • 1. Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.
    Sheikha GA; Al-Sha'er MA; Taha MO
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):603-9. PubMed ID: 21190426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity.
    Rowlands MG; Newbatt YM; Prodromou C; Pearl LH; Workman P; Aherne W
    Anal Biochem; 2004 Apr; 327(2):176-83. PubMed ID: 15051534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening for Hsp90 ATPase inhibitors.
    Avila C; Hadden MK; Ma Z; Kornilayev BA; Ye QZ; Blagg BS
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3005-8. PubMed ID: 16530412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of heat shock protein 90 targeted compounds.
    Cruz IN; Zhang Y; de la Fuente M; Schatzlein A; Yang M
    Anal Biochem; 2013 Jul; 438(2):107-9. PubMed ID: 23563445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Alkylsalicylic acid analogues inhibit in vitro ATPase activity of heat shock protein 90.
    Wu CZ; Moon AN; Choi O; Kang SY; Lee JJ; Lee D; Hwang BY; Kim YH; Lee HS; Hong YS
    Arch Pharm Res; 2010 Dec; 33(12):1997-2001. PubMed ID: 21191765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of Hsp90 inhibitors.
    Cheung KM; Matthews TP; James K; Rowlands MG; Boxall KJ; Sharp SY; Maloney A; Roe SM; Prodromou C; Pearl LH; Aherne GW; McDonald E; Workman P
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3338-43. PubMed ID: 15955698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined pharmacophore and structure-guided studies to identify diverse HSP90 inhibitors.
    Sanam R; Tajne S; Gundla R; Vadivelan S; Machiraju PK; Dayam R; Narasu L; Jagarlapudi S; Neamati N
    J Mol Graph Model; 2010 Feb; 28(6):472-7. PubMed ID: 20005756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure based design of heat shock protein 90 inhibitors acting as anticancer agents.
    Doddareddy MR; Thorat DA; Seo SH; Hong TJ; Cho YS; Hahn JS; Pae AN
    Bioorg Med Chem; 2011 Mar; 19(5):1714-20. PubMed ID: 21306907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inside the Hsp90 inhibitors binding mode through induced fit docking.
    Lauria A; Ippolito M; Almerico AM
    J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors.
    Saxena AK; Saxena S; Chaudhaery SS
    SAR QSAR Environ Res; 2010 Jan; 21(1):1-20. PubMed ID: 20373211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis.
    Koca İ; Özgür A; Er M; Gümüş M; Açikalin Coşkun K; Tutar Y
    Eur J Med Chem; 2016 Oct; 122():280-290. PubMed ID: 27376491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 90 regulates development in Dictyostelium discoideum.
    Sawarkar R; Roy N; Rao S; Raman S; Venketesh S; Suguna K; Tatu U
    J Mol Biol; 2008 Oct; 383(1):24-35. PubMed ID: 18718841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel class of Hsp90 inhibitors isolated by structure-based virtual screening.
    Park H; Kim YJ; Hahn JS
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6345-9. PubMed ID: 17869098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity.
    Avila C; Kornilayev BA; Blagg BS
    Bioorg Med Chem; 2006 Feb; 14(4):1134-42. PubMed ID: 16213144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design strategies to target crystallographic waters applied to the Hsp90 molecular chaperone.
    Kung PP; Sinnema PJ; Richardson P; Hickey MJ; Gajiwala KS; Wang F; Huang B; McClellan G; Wang J; Maegley K; Bergqvist S; Mehta PP; Kania R
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3557-62. PubMed ID: 21612924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90: chaperoning signal transduction.
    Richter K; Buchner J
    J Cell Physiol; 2001 Sep; 188(3):281-90. PubMed ID: 11473354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of coumermycin A1 analogues that inhibit the Hsp90 protein folding machinery.
    Burlison JA; Blagg BS
    Org Lett; 2006 Oct; 8(21):4855-8. PubMed ID: 17020320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
    Kamal A; Thao L; Sensintaffar J; Zhang L; Boehm MF; Fritz LC; Burrows FJ
    Nature; 2003 Sep; 425(6956):407-10. PubMed ID: 14508491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.